IL52544A0 - Alpha,omega-bis (heterocyclicguanidino) alkane derivative - Google Patents

Alpha,omega-bis (heterocyclicguanidino) alkane derivative

Info

Publication number
IL52544A0
IL52544A0 IL52544A IL5254477A IL52544A0 IL 52544 A0 IL52544 A0 IL 52544A0 IL 52544 A IL52544 A IL 52544A IL 5254477 A IL5254477 A IL 5254477A IL 52544 A0 IL52544 A0 IL 52544A0
Authority
IL
Israel
Prior art keywords
heterocyclicguanidino
omega
alpha
bis
alkane derivative
Prior art date
Application number
IL52544A
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of IL52544A0 publication Critical patent/IL52544A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26Radicals substituted by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL52544A 1976-07-28 1977-07-18 Alpha,omega-bis (heterocyclicguanidino) alkane derivative IL52544A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3139176 1976-07-28

Publications (1)

Publication Number Publication Date
IL52544A0 true IL52544A0 (en) 1977-10-31

Family

ID=10322405

Family Applications (1)

Application Number Title Priority Date Filing Date
IL52544A IL52544A0 (en) 1976-07-28 1977-07-18 Alpha,omega-bis (heterocyclicguanidino) alkane derivative

Country Status (15)

Country Link
JP (1) JPS5315370A (en)
AU (1) AU2734677A (en)
BE (1) BE857218A (en)
CA (1) CA1070315A (en)
DE (1) DE2733953A1 (en)
DK (1) DK331877A (en)
ES (1) ES461100A2 (en)
FI (1) FI772293A (en)
FR (1) FR2359840A1 (en)
IL (1) IL52544A0 (en)
LU (1) LU77845A1 (en)
NL (1) NL7708375A (en)
NO (1) NO772668L (en)
PL (1) PL107847B1 (en)
ZA (1) ZA774552B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309435A (en) 1978-10-16 1982-01-05 Imperial Chemical Industries Ltd. Antisecretory guanidine derivatives and pharmaceutical compositions containing them
FR2446829A1 (en) 1978-11-16 1980-08-14 Glaxo Group Ltd POLYMETHYLENE DERIVATIVES DISUBSTITUTED IN ALPHA, OMEGA, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
JPS57102852A (en) * 1980-12-19 1982-06-26 Shionogi & Co Ltd Dicarboxylic acid diamide
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Also Published As

Publication number Publication date
LU77845A1 (en) 1977-10-25
JPS5315370A (en) 1978-02-13
DK331877A (en) 1978-01-29
PL199908A1 (en) 1978-11-20
NO772668L (en) 1978-01-31
FR2359840A1 (en) 1978-02-24
NL7708375A (en) 1978-01-31
ZA774552B (en) 1978-06-28
CA1070315A (en) 1980-01-22
DE2733953A1 (en) 1978-02-02
ES461100A2 (en) 1978-12-01
PL107847B1 (en) 1980-03-31
BE857218A (en) 1978-01-27
AU2734677A (en) 1979-02-01
FI772293A (en) 1978-01-29

Similar Documents

Publication Publication Date Title
CY1155A (en) 2-piperazinyl-6,7-dimethoxyquinazolines
PH20254A (en) 1,2 dihydro-2-oxo-(pyridiny,) nicotinanide
NZ181619A (en) 1-aminoalkoxy-4-substituted-1 2, 3, 4-tetrahydroiso-quinolines
GB1524917A (en) Gona-1,9(10)-dienes
FI65422B (en) FOERFARANDE FOER FRAMSTAELLNING AV 2,4,6-TRI (3,5-DITERT -BUTYL-4-HYDROXIBENSYL) -MESITYLEN
NL162747C (en) REFLECTION-REDUCING MULTI-LAYER SYSTEM.
GB1520958A (en) 11-deoxy-16-aryl - 17,18,19,20 - tetranorprostaglandins
YU135877A (en) Closer,particularly for mechanical vises
IL52545A0 (en) Alpha,omega-bis (heterocyclicguanidino) alkane derivates
IL48624A0 (en) 2,3-dihydroergolines
IL52544A0 (en) Alpha,omega-bis (heterocyclicguanidino) alkane derivative
PH14168A (en) 2,4-pyrrolidinediones
AU1214076A (en) 2,3-dihalogen-alkanoyl-ureas
PH13008A (en) 9-hydroxy-7,8,9,10-tetrahydro-6h-dibenzo(b)(d)pyrans
ZA774515B (en) O-ethyl-s-n-propyl-o-2,2,2-trihaloethylphosphorothiolates(or thionothiolates)
HK36785A (en) 1-amino-alkyl-3,4-diphenyl-1h-pyrazoles
BE858866A (en) 2,5-METHANOBENZO (G) QUINOLEINE-3-CARBOXYLATES (ESTERS)
GB1554021A (en) 4,5-didehydroprostaglandins
NZ182127A (en) 6 ,17 -dihydroxy-1 -loweralkoxycarbonyl-3-oxo-17 -pregn-4-ene-21-carboxylic acid -lactones
PH14888A (en) 1,2,3,4-tetrahydro-9h-pyrrolo(3,4-b)quinolin-9-one derivative
ZA766301B (en) Substituted 2,1,3-benzothiadiazine
IE44206L (en) 8 -aminoergoline i derivatives.
GB1554925A (en) 2,3-methyl-eneprostaglandins
GB1554049A (en) 2-decarboxy-2-hydroxymethyl-13,14-didehydroprostaglandins
IT1065700B (en) PROCEDURE FOR PREPARING CARBAMMOIL-1 (DICHLORO-3,5 FENIL) -3 IDANTOINE